Introduction
Mental retardation (MR), defined as an intelligence quotient below 70, is the most frequent handicap in children, affecting 1% to 3% of the general population. 1 Despite recent advances, the causes of nearly 40% of MR remain unclear. Although a considerable number of X-linked MR (XLMR) genes are known, only four genes causing autosomal-recessive nonsyndromic MR (AR-NSMR) have been identified so far: PRSS12 (MIM 606709), 2 CRBN (MIM 609262), 3 CC2D1A (MIM 610055), 4 and GRIK2 (MIM 138244). 5 These genes are involved in different pathways, namely synaptic proteolysis, regulation of mitochondrial energy metabolism, regulation of I-kB kinase/NF-kB cascade, and induction of long-term potentiation (LTP), underlining the extreme heterogeneity of the pathophysiological mechanism involved in these diseases. Glycosylation is an important posttranslational modification that occurs in every cell and has a significant impact on numerous biological processes. Many defects in the asparagine-linked glycosylation (N-glycosylation) have been identified in congenital disorders of glycosylation (CDG) syndromes. 6, 7 Their diagnosis is based on the identification of underglycosylated transferrin, either by isoelectric focusing or mass-spectrometry analyses. Clinically, CDG syndromes are characterized by psychomotor retardation, ataxia, failure to thrive, dysmorphic features, and coagulopathies. To date, 18 different CDG subtypes have been described: 12 types in group I CDG and six in group II. Group I CDG results in the disrupted synthesis of the oligosaccharide chain, whereas group II CDG is defined as defects in the processing of the protein-bound glycan. 6 In eukaryotic cells, the key step of the N-glycosylation is mediated by the oligosaccharyltransferase (OTase), an oligomeric membrane-protein complex that catalyzes the transfer of preassembled high-mannose oligosaccharide onto asparagine residues of nascent polypeptides entering the lumen of the endoplasmic reticulum. 8 There are at least two mam- 8 and, to date, no mutation in any of these subunits has ever been highlighted in a human disease.
In this article, we show that mutations in two OTasesubunit genes, N33/TUSC3 and IAP (also named MAGT1), the Ost3 and Ost6 Saccharomyces cerevisae human orthologs, respectively, result in NSMR. These data expand the spectrum of the CDG syndromes and emphasize the crucial role of glycosylation activity in higher brain functions and cognitive development.
Material and Methods

Subjects and Families
Family 1
Affected children are 32 and 25 yr old, respectively. In both cases, pregnancy and delivery were uneventful (patient V.1: length 47 cm, weight 3050 g, head circumference 35.5 cm; patient V.4: length 49 cm, weight 3400 g, head circumference 35 cm), and no postnatal infection, toxic exposure, or significant head trauma was noted. Standard assessment revealed significant developmental delay in the two sibs (independent walking at 3 and 2.5 yr, respectively; no speech at 3 and 4 yr, respectively). Mental retardation could be estimated as severe and appeared nonprogressive. Physical examination of both patients at 31 and 24 yr of age was unremarkable, with normal height, weight, and head circumference. Examination showed no malformations and normal metabolic screening (amino acid chromatography, blood lactate and pyruvate levels, liver function, and ammonemia). Molecular testing ruled out fragile X syndrome. High-resolution chromosome analysis, bone X-rays, cerebral MRI, and electroencephalogram were all normal.
Family 2
In this sibship of five children (one healthy girl, two girls with mild MR, and two boys with severe MR), only one affected boy (III.5, 62 yr old) is still alive; the other affected individuals (III.6) are deceased of liver or cervical cancer. The two affected males had a similar phenotype with the same degree of handicap. Both were in educational classes for the moderately handicapped. They were both able to hold a limited conversation; neither learned to read or write. Both were on disability pensions as adults. III.5 is in protected employment in a gardening team, and he lives independently and cooks his own meals but is visited very regularly by his sister, who supervises his affairs. When 59 yr old, he had normal growth parameters (height 166 cm; head circumference 57 cm). Their mother (II.2) was described as slow. One sister (III.4) who is deceased was in a special class for the mildly handicapped at school but was not as slow as the brothers.
Microarray Analysis
The 10K Array contains 11,555 single-nucleotide polymorphisms (SNPs) covering the whole human genome with a mean genetic map distance of 0.32 cM. The average distance between the SNPs is 210 kb, and the average heterozygosity of these SNPs is 0.37. According to the manufacturer's instructions, 250 ng total genomic DNA was digested with a restriction enzyme (XbaI) and ligated to adaptors that recognize the cohesive 4 bp overhangs. Amplification, purification, labeling, and hybridization of PCR products were performed as recommended by the manufacturer. Results were analyzed with the GeneChip DNA Analysis software 3.0 (GDAS 3.0), and parametric linkage analyses were subsequently done with the Merlin program.
Mutation Screening of the N33/TUSC3 and IAP Genes
Blood samples were obtained from siblings and their parents of family 1 after informed consent, and genomic DNA was isolated from blood leucocytes with the Nucleon kit (Amersham) according to the manufacturer's instructions. Genomic DNA from family 2 probands was isolated, after informed consent, from a lymphoblastoid cell line (patient III.5), from a Guthrie test sample (patient III.6), and from blood samples (patient III.2, III.3, IV.1, IV.2, and IV.3). Specific primers for PCR amplification of exons and splicing junctions of N33/TUSC3 and IAP were designed on the basis of their sequence data from the GenBank database (NT_030737 and NT_113965, primer sequences are available on request). PCR products were purified with Exo-SAP (Amersham) and directly sequenced on an automated sequencer (ABI 3130xl, Applied Biosystems) via the dye-terminator method.
Expression Analyses of the N33/TUSC3
and IAP Genes by RT-PCR 
Quantitative Real-Time RT-PCR
The level of N33/TUSC3, Vimentin (Vim), and Beta-actin (ACTB) mRNA expression were studied with specific primers designed according to GenBank sequence database: N33/TUSC3, forward 5 0 -G Figure 2 . Quantitative PCR Analysis of N33/TUSC3 mRNA N33/TUSC3 expression in fibroblasts from two controls (black and white bars) and patient V.1 (gray bar to assess the specificity of each transcript amplified. All reactions were performed in duplicate. For each amplification, a standard calibration using a control cDNA with different dilutions was performed. Relative expression was assessed with the calculated concentration in respect to the standard, so that a ratio of 1 represents an average ratio between N33/TUSC3 mRNA and Vim or ACTB mRNA in control samples.
Cell Culture
Primary fibroblasts from patients and controls were cultured at 37 C under 5% CO2 in RPMI 1640/Glutamax (Invitrogen) supplemented with 10% of fetal calf serum (Invitrogen).
Release of the N-Linked Oligosaccharides and CleanUp Procedure of the PNGase F-Released N-Glycans
Twenty microliters of serum were dried in a vacuum centrifuge. The N-glycans were released and purified as previously described.
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Permethylation of the Glycans and MALDI-TOF-MS
Permethylation of the freeze-dried glycans and MALDI-TOF-MS analyses of permethylated glycans were performed as described elsewhere. 
Results
Linkage Analysis of Family 1
We had the opportunity to study two sibs born to secondcousin French parents (family 1, Figure 1A ) and presenting NSMR. Autozygosity mapping, with the Affymetrix GeneChip Human Mapping 10K array, in both affected and healthy children and in parents identified a unique homozygous region on chromosome 8p22-p23.1 ( Figure 1A ). Further polymorphic marker analyses reduced the critical region to an 8 Mb interval (maximum LOD Direct sequencing of all coding exons and exon-intron junctions identified a 1 bp homozygous insertion in exon 6, c.787_788insC ( Figure 1B ). This frameshift mutation (p.N263fsX300) cosegregated with the disease and was predicted to cause the premature termination of translation and the synthesis of a truncated N33/TUSC3 protein lacking the 84 C-terminal amino acids ( Figure 1C ). This variant was not found in 250 control chromosomes from various ethnic origins (90% of European descent, 10% North African).
Functional Analysis of N33 Mutation
The consequence of the c.787_788insC sequence variant on N33/TUSC3 expression was assessed by reverse-transcription PCR (RT-PCR) of cultured skin fibroblast RNAs of patient V.1. No aberrant mRNA but a reduced amount of transcript was observed. Quantitative real-time RT-PCR (qRT-PCR) with the Light Cycler technology showed a significantly reduced amount of N33/TUSC3 mRNA in patient V.1 fibroblasts as compared to two controls for which two housekeeping genes were used (from 54.1% to 79.1% of reduction, p < 0.001, Figure 2 ). These results suggest that the primary effect of this frameshift mutation is nonsense-mediated decay of the N33/TUSC3 mRNA.
Glycosylation Analysis in Cells Harboring the N33 Mutation
Because isoelectric focusing showed no alteration of serum-transferrin glycosylation (data not shown), we undertook the mass-spectrometry characterization of N-glycan structures of glycoproteins isolated from the patient's se- rum. 10 The MALDI-TOF spectra of permethylated N-glycans obtained by deglycosylation of serum glycoproteins of patients V.1 and V.4 were compared to a control serum sample ( Figures 3A-3C Figure 3D ), suggesting that the N33/TUSC3 mutation did not lead to global N-glycan transfer impairment.
Mutation Screening of N33 Paralog, the IAP Gene The OTase subunit Ost3p and its paralog Ost6p have been originally identified in yeast. 11, 12 They share 20% of sequence identity and display a strikingly similar membrane topology. In addition to the N33/TUSC3 gene, mammalian genomes also contain an Ost6 ortholog, named IAP, which maps to Xq21.1 and composed of ten coding exons. We therefore investigated whether IAP gene mutations could account for MR. We first sequenced all coding exons and exon-intron junctions in a series of 18 probands in XLMR families linked to the Xq21.1 region, and no mutation was found. Then, we took advantage of the International Genetics of Learning Disabilities program, which undertook a systematic, high-throughput mutational screen of the VEGA-annotated X chromosome gene set (737 genes) in 250 MR families. 13 One proband per family had been previously tested for karyotype anomalies, FMR1 Figure 5 . Expression Analyses of N33/ TUSC3, IAP, and Vimentin Expression was asseyed by RT-PCR on adult and fetal total RNA isolated from various tissues (Clontech): fetal liver (F.liv), heart, kidney (Kid.), adult liver (Ad.liv), lung, placenta (Pl.), prostate (Pr.), salivary gland (Sal.g), skeletal muscle (Sk.m), testis, thymus, thyroid gland (Thyr.g), trachea (Tr.), uterus (Ut.), fetal chondrocytes (F.ch), and osteoblasts (Ost.). Amplicon length of N33/TUSC3, IAP, and Vimentin (Vim) are indicated in bp. Figure 4B ). The p.V311G variant cosegregated with the disease ( Figure 4A ) and involved a highly conserved amino acid ( Figure 4C ). This variant was not found in 267 control X chromosomes. Neither N33/TUSC3 nor IAP mRNA was expressed in lymphoblastoid cell lines, and no skin fibroblasts from this patient were available, ruling out the possibility of testing the impact of this mutation at the RNA level.
Tissue Distribution of N33 and IAP mRNA To get further insight in the functional consequences of the N33/TUSC3 and IAP mutations, we undertook the analysis of their expression by RT-PCR in various adult and fetal tissues. As shown in Figure 5 , both genes were found ubiquitously expressed, including in fetal and adult brain structures tested ( Figure 6A ). Noticeably, N33/TUSC3 expression was found more abundant in total fetal brain ( Figure 6A ).
Discussion Surprisingly, although the OTase complex plays a key role in N-glycosylation, no OTase subunit mutations have been hitherto identified in human. To our knowledge, our data provide the first demonstration that mutations in OTase subunits are responsible for isolated cognitive deficit, thus expanding the spectrum of CDG syndromes. Interestingly, a separate study has identified a homozygous deletion of a portion of the N33/TUSC3 gene that segregates with MR in a large consanguineous family, further supporting the conclusion that N33/TUSC3 defects are responsible for autosomal-recessive nonsyndromic MR. 14 In the meantime, these results raise the issue of understanding how mutations in genes involved in an essential and ubiquitous cellular process could result in a CNS-restricted phenotype.
It is worth remembering that in Saccharomyces cerevisae, two distinct isoforms of OTase exist, only differing by the inclusion of either Ost3p or Ost6p. 15, 16 Neither Ost3p nor Ost6p is absolutely required for OTase activity. Indeed, disruption of either yeast Ost3 or Ost6 genes only caused a moderate hypoglycosylation phenotype, whereas the double Dost3Dost6 mutation led to a severe N-glycosylation defect. 12 Moreover, when overexpressed, they could displace each other, suggesting a dynamic regulation of the complex. 12 Our data suggest that it might also be the case in human, at least in fibroblasts cells, where IAP could functionally compensate for the lack of N33/TUSC3 protein, thus resulting in a normal N-glycosylation in all but neuronal cells. Alternatively, the two proteins could also be involved in the glycosylation of a subset of proteins essential for normal brain function. This hypothesis is further supported by the data from B. Schultz and colleagues, who demonstrated that Ost3p and Ost6p subunits may determine, to some extent, the substrate specificity of OTase complexes (personal communication). Indeed, on the basis of a multidisciplinary approach, this group has demonstrated that in yeast, Ost3p and Ost6p have disulfide reductase and peptide-binding activities, which modulate the oxidative folding of specific glycoproteins, thereby allowing glycosylation of defined acceptor sites. In addition, their results demonstrate that each protein has distinct site specificity, because different sites were underglycosylated in Ost3 or Ost6 yeast mutants. Given that most N-glycosylation sites do not require reductase activity, these data are consistent with the absence of a hypoglycosylation phenotype of standard glycoproteins observed in patients and point to a specific hypoglycosylation of proteins that are required for normal higher-brain functions.
Cognitive dysfunction is generally regarded as the consequence of a defect in synapse formation and plasticity, especially in the postnatal stage, during learning and acquisition of intellectual performance and emotional behavior. Some evidence supports a close link between long-term potentiation (LTP) and memory storage. 17, 18 Along these lines, it is worth remembering that disruption of N-glycosylation by specific inhibitors, such as Tunicamycin or Swainsonine, had a direct effect on transition of short-term potentiation into a long-lasting maintenance of hippocampal LTP. 19 Further studies will hopefully clarify the nature of the specific carbohydrate structure and the identity of the proteins carrying such plasticity-relevant structures. Yet, the involvement of L1 and neural cell-adhesion molecules (L1CAM and NCAM) is already supported by several observations, and polysialic acid (PSA) modification of NCAM supports the critical role of glycosylation in synaptic plasticity and memory consolidation. [20] [21] [22] [23] Furthermore, in brain, PSA is attached to NCAM in a developmentally regulated manner. PSA-NCAM is associated with morphogenetic changes during development (cell migration, synaptogenesis), whereas PSA-NCAM is low in adult brain except in regions with a high degree of plasticity (hippocampus, hypothalamus, olfactory bulb). 24, 25 PSA has a high negative-charge density, which might decrease adhesion strength of cell interactions 26 and be needed for synapse remodeling. Facilitating synaptic plasticity induces formation and stabilization of a long-lasting memory trace. Finally, mutations in L1CAM are associated with neurodevelopmental disorders including X-linked hydrocephalus and MR, and several amino acid substitutions identified in patients have been shown to alter the glycosylation pattern of this protein. 27 In conclusion, the results reported here emphasize the crucial role of OTase activity in higher-brain function and expand the field of the pathophysiology of mental retardation.
